Chengdu NewRT Medical Technology
PrivateLast Round
Series E
Apr 3, 2026
Est. Valuation
$110M
Total Funding Raised
$313.17M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Chengdu NewRT Medical Technology operates in Healthcare & Life Sciences and is based in Chengdu. Its latest recorded funding round was a Series E round in April 2026.
Chengdu NewRT Medical Technology is a biotechnology company that develops and produces medical isotopes and radiopharmaceuticals for the diagnosis and treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chengdu NewRT Medical Technology Comparables
Compare Chengdu NewRT Medical Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yantai Dongcheng Pharmaceutical Group Co., Ltd. | 82% | |
| Eli Lilly and Company | 82% | |
| C-Ray Therapeutics | 78% |
For institutional investors. Book with your work email.
Chengdu NewRT Medical Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Apr 3, 2026 | ||||
| Series D | Oct 10, 2025 | ||||
| Series C | Mar 14, 2024 | ||||
| Series B | Jul 16, 2019 |
For institutional investors. Book with your work email.
Chengdu NewRT Medical Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series E |
| Chengdu Aerotropolis Innovation & Venture Capital | Series D |
| PICC Capital Insurance Asset Management | Series D |
| Xingkong Capital | Series C |
| Hunan Provincial Caixin Industrial Fund Management | Series D |
| Efung Capital | Series E |
| Shenzhen Capital Group | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 399, 4433% of headcount.
- Jul 13, 2026
Open roles increased to 332, 3.8x the trailing average.
For institutional investors. Book with your work email.
Chengdu NewRT Medical Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Chengdu NewRT Medical Technology's valuation, stock price, and market status.
Is Chengdu NewRT Medical Technology a public or private company?
Chengdu NewRT Medical Technology is a private company.
What is the current stock price of Chengdu NewRT Medical Technology?
Chengdu NewRT Medical Technology is a private company, so its shares have no public market price. Caplight tracks Chengdu NewRT Medical Technology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Chengdu NewRT Medical Technology worth (valuation)?
Chengdu NewRT Medical Technology's valuation is estimated at $110.0M based on funding round data.
Can I buy Chengdu NewRT Medical Technology stock?
Chengdu NewRT Medical Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Chengdu NewRT Medical Technology's last funding round?
Chengdu NewRT Medical Technology's most recent funding round was Series E on April 3, 2026.
Who are the main investors in Chengdu NewRT Medical Technology?
Key investors in Chengdu NewRT Medical Technology include PICC Capital Insurance Asset Management, Shenzhen Capital Group.
Will Chengdu NewRT Medical Technology IPO soon?
No public IPO plans have been announced for Chengdu NewRT Medical Technology.
How can I track Chengdu NewRT Medical Technology secondary market activity?
Caplight tracks bids, offers, and trades in Chengdu NewRT Medical Technology's shares on secondary markets.